LYNG21: Ably LYNG Clinical Demonstration in Operative Environment
NCT ID: NCT05117606
Last Updated: 2021-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2021-05-25
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specifically, the LYNG study objectives are as follows:
1. collect sensor data from LYNG Solution to optimize the LYNG data algorithms to further improve parameter estimations of patient heart rate, respiratory rate, blood pressure and movement indicators.
2. Compare parameter estimation by LYNG against current and relevant standard of care measurement methods
The study design is a within-subjects comparison in parameter estimation with Ably LYNG as comparator to standard of care. Patients will take part in 60-minute sessions where measurements are collected in accidence to standard procedure for the standard equipment while the LYNG system collects the same data non- intrusively. The data will not be part of any clinical decision making or have any impact of the patient care. The study will take place during Q2-Q3/2021 with estimated 8-12 weeks duration including logistics, setup, data collection, study closure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitalsigns
Data from patients (heart rate, respiration, movement, blood pressure) is measured with traditional, standard hospital equipment in parallell with data from LYNG mat captured non-intrusively in the same session.
LYNG by Ably Medical
Comparing LYNG to traditional, standard equipment for heart rate, respiration, movement, and blood pressure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LYNG by Ably Medical
Comparing LYNG to traditional, standard equipment for heart rate, respiration, movement, and blood pressure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to hospital,
* Able to provide voluntary, informed consent.
Exclusion Criteria
* Health condition that endangers patient by participation due to pain, rehabilitation, and/or negative impact on treatment or care, as evaluated by medical personnel,
* Pregnancy,
* Significantly reduced mobility that implies substantial strain for moving in and out of bed, as evaluated by medical personnel
* Unable to provide informed, voluntary consent personally or by legal guardian, \* below 18 years old,
* Patients with implantable devices such as pacemakers, baclofen pumps, insulin pumps, etc, or
* Any way identified as 'vulnerable'
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alesund Hospital
OTHER
Ably Medical AS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dag A Lihaug Hoff
Role: PRINCIPAL_INVESTIGATOR
HMR Aalesund Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helse Møre og Romsdal HF - Aalesund Sjukehus
Ålesund, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LYNG21_AALESUND
Identifier Type: -
Identifier Source: org_study_id